Cargando…

The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens

BACKGROUND: The interaction of environmental factors with genetic susceptibility and detoxification level seems to be an important causative factor in bladder cancer (BC). The aim of this study was to look for a BC marker panel which reflects the environmental risk. The nuclear matrix protein 22 (NM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymańska, Beata, Sawicka, Ewa, Guzik, Anna, Zdrojowy, Romuald, Długosz, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591903/ https://www.ncbi.nlm.nih.gov/pubmed/28929116 http://dx.doi.org/10.1155/2017/9643139

Ejemplares similares

Preliminary Study on Selected Markers of Oxidative Stress, Inflammation and Angiogenesis in Patients with Bladder Cancer
por: Sawicka, Ewa, et al.
Publicado: (2019)

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis
por: Szymańska, B., et al.
Publicado: (2018)

The diagnostic and prognostic value of nuclear matrix protein 22 in bladder cancer
por: Tang, Xingxing, et al.
Publicado: (2020)

Low molecular weight proteins and enzymes in the urine of patients with bladder cancer – a pilot study
por: Marchewka, Zofia, et al.
Publicado: (2018)

The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status
por: Nowak, Łukasz, et al.
Publicado: (2020)

The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2α, ɣ-Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study
por: Szymańska, Beata, et al.
Publicado: (2020)

Oxidative stress parameters as biomarkers of bladder cancer development and progression
por: Wigner, Paulina, et al.
Publicado: (2021)

Uroplakins and their potential applications in urology
por: Matuszewski, Michal Andrzej, et al.
Publicado: (2016)

Technical developments in transurethral resection of bladder tumours
por: Pastuszak, Agata, et al.
Publicado: (2019)

Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer
por: Matuszewski, M., et al.
Publicado: (2018)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
por: KRAJEWSKI, WOJCIECH, et al.
Publicado: (2020)

Combination of histological and molecular data for improving outcome prediction in non-muscle invasive bladder cancer—narrative review
por: Piszczek, Radosław, et al.
Publicado: (2020)

Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
por: Piszczek, Radosław, et al.
Publicado: (2020)

Management of bladder neck leiomyoma during pregnancy
por: Tupikowski, Krzysztof, et al.
Publicado: (2011)

The Usefulness of Lymphadenectomy in Bladder Cancer—Current Status
por: Małkiewicz, Bartosz, et al.
Publicado: (2021)

Giant Congenital Melanocytic Nevi: Selected Aspects of Diagnostics and Treatment
por: Sawicka, Ewa, et al.
Publicado: (2015)

Does restaging transurethral resection of bladder tumour influence outcomes in patients treated with BCG immunotherapy? 491 cases in 20 years’ experience
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Diagnostic and treatment delays among patients with primary bladder cancer in Poland: a survey study
por: Mielczarek, Łukasz, et al.
Publicado: (2020)

COVID-19 and the urological practice: changes and future perspectives
por: Nowak, Łukasz, et al.
Publicado: (2020)

Environmental Carcinogens and Cancer Risk
por: Gatto, Nicole M.
Publicado: (2021)

The Prognostic Value of the Surface Electromyographic Assessment of Pelvic Floor Muscles in Women with Stress Urinary Incontinence
por: Ptaszkowski, Kuba, et al.
Publicado: (2020)

Molecular and Cellular Aspects of Carcinogen Screening Tests
por: Fox, M.
Publicado: (1981)

Important aspects of the evidence for TCDD carcinogenicity in man.
por: Johnson, E S
Publicado: (1993)

The Influence of Interaction between Cadmium with 17β-Estradiol, 2-Methoxyestradiol and 16α-Hydroxyestrone on Viability and p-Glycoprotein in Ovarian Cancer Cell Line
por: Sawicka, Ewa, et al.
Publicado: (2022)

Assessment of Pain Management, Acceptance of Illness, and Adjustment to Life with Cancer in Patients with Nonmuscle Invasive Bladder Cancer
por: Krajewski, Wojciech, et al.
Publicado: (2018)

Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta‐analysis
por: Wang, Jie, et al.
Publicado: (2022)

Oxidative Stress in the Carcinogenicity of Chemical Carcinogens
por: Kakehashi, Anna, et al.
Publicado: (2013)

Environmental Carcinogens selected Methods of Analysis
por: Kinsella, A.
Publicado: (1982)

Epidemiological Research on Occupational and Environmental Carcinogens
por: Ledda, Caterina
Publicado: (2021)

The role of lasers in modern urology
por: Dołowy, Łukasz, et al.
Publicado: (2015)

Vitamin D and urological cancers
por: Krajewski, Wojciech, et al.
Publicado: (2016)

How to lower postoperative complications after radical cystectomy – a review
por: Krajewski, Wojciech, et al.
Publicado: (2016)

Evaluation and physiopathology of minor transient shock wave lithotripsy – induced renal injury based on urinary biomarkers levels
por: Dzięgała, Mateusz, et al.
Publicado: (2018)

The genetics of obesity - Pathogenetic, clinical and diagnostic aspects
por: Barczyk, Artur, et al.
Publicado: (2017)

DNA adducts and related biomarkers in populations exposed to environmental carcinogens
por: Perera, Frederica, et al.
Publicado: (1992)

Systematic review and meta-analysis on bipolar versus monopolar transurethral resection of bladder tumors
por: Krajewski, Wojciech, et al.
Publicado: (2021)

Interindividual variation in carcinogen metabolism and bladder cancer risk.
por: Vineis, P, et al.
Publicado: (1992)

Detection of carcinogen-induced bladder cancer by fluorocoxib A
por: Bourn, Jennifer, et al.
Publicado: (2019)

Urological complications after radiation therapy—nothing ventured, nothing gained: a Narrative Review
por: Chorbińska, Joanna, et al.
Publicado: (2021)

Some historical aspects of N-aryl carcinogens and their metabolic activation.
por: Miller, J A, et al.
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_nshe09n16or4hs234vrtdd46vp